These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15271961)

  • 1. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major.
    Santiago HC; Oliveira CF; Santiago L; Ferraz FO; de Souza D G; de-Freitas LA; Afonso LC; Teixeira MM; Gazzinelli RT; Vieira LQ
    Infect Immun; 2004 Aug; 72(8):4918-23. PubMed ID: 15271961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell degranulation contributes to susceptibility to Leishmania major.
    Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ
    Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major.
    Antoniazi S; Price HP; Kropf P; Freudenberg MA; Galanos C; Smith DF; Müller I
    Infect Immun; 2004 Sep; 72(9):5168-74. PubMed ID: 15322011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2-independent role of CCR2 in immune responses against Leishmania major.
    Quinones MP; Estrada CA; Jimenez F; Martinez H; Willmon O; Kuziel WA; Ahuja SK; Ahuja SS
    Parasite Immunol; 2007 Apr; 29(4):211-7. PubMed ID: 17371458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
    Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
    Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
    Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
    Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
    Menon JN; Bretscher PA
    Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
    Wershil BK; Theodos CM; Galli SJ; Titus RG
    J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
    Matte C; Olivier M
    J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
    Erb K; Blank C; Ritter U; Bluethmann H; Moll H
    Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent BALB/c mice are able to develop resistance to Leishmania major infection.
    Ehrchen J; Sindrilaru A; Grabbe S; Schönlau F; Schlesiger C; Sorg C; Scharffetter-Kochanek K; Sunderkötter C
    Infect Immun; 2004 Sep; 72(9):5106-14. PubMed ID: 15322004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
    Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
    J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.
    Sunderkötter C; Kunz M; Steinbrink K; Meinardus-Hager G; Goebeler M; Bildau H; Sorg C
    J Immunol; 1993 Nov; 151(9):4891-901. PubMed ID: 8409447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice.
    Doherty TM; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):124-35. PubMed ID: 8932762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.